AU2021321705B2 - Novel cycloalkenone compound or salt thereof - Google Patents
Novel cycloalkenone compound or salt thereof Download PDFInfo
- Publication number
- AU2021321705B2 AU2021321705B2 AU2021321705A AU2021321705A AU2021321705B2 AU 2021321705 B2 AU2021321705 B2 AU 2021321705B2 AU 2021321705 A AU2021321705 A AU 2021321705A AU 2021321705 A AU2021321705 A AU 2021321705A AU 2021321705 B2 AU2021321705 B2 AU 2021321705B2
- Authority
- AU
- Australia
- Prior art keywords
- compound
- group
- salt
- methyl group
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
- C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C235/78—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/31—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/18—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020-135328 | 2020-08-07 | ||
| JP2020135328 | 2020-08-07 | ||
| PCT/JP2021/029246 WO2022030606A1 (ja) | 2020-08-07 | 2021-08-06 | 新規なシクロアルケノン化合物又はその塩 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2021321705A1 AU2021321705A1 (en) | 2023-03-09 |
| AU2021321705B2 true AU2021321705B2 (en) | 2024-02-29 |
Family
ID=80118163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2021321705A Active AU2021321705B2 (en) | 2020-08-07 | 2021-08-06 | Novel cycloalkenone compound or salt thereof |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230295068A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4194435A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7109705B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102974166B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN116096361B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021321705B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023001832A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3188292A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023001536A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI829001B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022030606A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023153422A1 (ja) * | 2022-02-09 | 2023-08-17 | 大鵬薬品工業株式会社 | シクロヘキセノン化合物の結晶形 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001515058A (ja) * | 1997-08-13 | 2001-09-18 | 明治乳業株式会社 | シクロヘキセノン長鎖アルコール及びこれを含有する医薬 |
| JP2002241271A (ja) * | 2001-02-19 | 2002-08-28 | Meiji Milk Prod Co Ltd | 排尿障害治療剤 |
| JP2019504018A (ja) * | 2015-12-17 | 2019-02-14 | バイオエレクトロン テクノロジー コーポレイション | 酸化ストレス障害を処置するためのフルオロアルキル、フルオロアルコキシ、フェノキシ、ヘテロアリールオキシ、アルコキシ、およびアミノ1,4−ベンゾキノン誘導体 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009111576A2 (en) * | 2008-03-05 | 2009-09-11 | Edison Pharmaceuticals, Inc. | 2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES |
| TWI501968B (zh) * | 2010-11-12 | 2015-10-01 | Merck Sharp & Dohme | 六氫吡啶酮甲醯胺氮雜茚滿cgrp受體拮抗劑 |
| CA2883879A1 (en) * | 2012-09-07 | 2014-03-13 | Edison Pharmaceuticals, Inc. | Quinone derivatives for use in the modulation of redox status of individuals |
| RU2729186C2 (ru) | 2016-01-22 | 2020-08-05 | Тайхо Фармасьютикал Ко., Лтд. | Способ производства длинноцепочечного спирта циклогексенона высокой степени очистки |
| TWI831738B (zh) * | 2016-12-16 | 2024-02-11 | 美商瑞塔醫藥有限責任公司 | 用於抑制RORγ及其他用途的嘧啶三環烯酮衍生物 |
-
2021
- 2021-08-06 CN CN202180057124.1A patent/CN116096361B/zh active Active
- 2021-08-06 MX MX2023001536A patent/MX2023001536A/es unknown
- 2021-08-06 TW TW110129168A patent/TWI829001B/zh active
- 2021-08-06 EP EP21853226.5A patent/EP4194435A4/en active Pending
- 2021-08-06 CA CA3188292A patent/CA3188292A1/en active Pending
- 2021-08-06 WO PCT/JP2021/029246 patent/WO2022030606A1/ja not_active Ceased
- 2021-08-06 US US18/040,862 patent/US20230295068A1/en active Pending
- 2021-08-06 AU AU2021321705A patent/AU2021321705B2/en active Active
- 2021-08-06 BR BR112023001832A patent/BR112023001832A2/pt unknown
- 2021-08-06 KR KR1020237006213A patent/KR102974166B1/ko active Active
- 2021-08-06 JP JP2022518890A patent/JP7109705B2/ja active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001515058A (ja) * | 1997-08-13 | 2001-09-18 | 明治乳業株式会社 | シクロヘキセノン長鎖アルコール及びこれを含有する医薬 |
| JP2002241271A (ja) * | 2001-02-19 | 2002-08-28 | Meiji Milk Prod Co Ltd | 排尿障害治療剤 |
| JP2019504018A (ja) * | 2015-12-17 | 2019-02-14 | バイオエレクトロン テクノロジー コーポレイション | 酸化ストレス障害を処置するためのフルオロアルキル、フルオロアルコキシ、フェノキシ、ヘテロアリールオキシ、アルコキシ、およびアミノ1,4−ベンゾキノン誘導体 |
Also Published As
| Publication number | Publication date |
|---|---|
| TW202216650A (zh) | 2022-05-01 |
| CA3188292A1 (en) | 2022-02-10 |
| JP7109705B2 (ja) | 2022-07-29 |
| KR20230043923A (ko) | 2023-03-31 |
| EP4194435A1 (en) | 2023-06-14 |
| US20230295068A1 (en) | 2023-09-21 |
| JPWO2022030606A1 (cg-RX-API-DMAC7.html) | 2022-02-10 |
| CN116096361B (zh) | 2025-10-10 |
| WO2022030606A1 (ja) | 2022-02-10 |
| KR102974166B1 (ko) | 2026-06-09 |
| BR112023001832A2 (pt) | 2023-02-23 |
| TWI829001B (zh) | 2024-01-11 |
| EP4194435A4 (en) | 2024-09-25 |
| AU2021321705A1 (en) | 2023-03-09 |
| CN116096361A (zh) | 2023-05-09 |
| MX2023001536A (es) | 2023-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3893889B1 (en) | Thrb receptor agonist compound and preparation method and use thereof | |
| EP3650449B1 (en) | Fxr receptor agonist | |
| US11208418B2 (en) | Nitrogenous tricyclic compounds and uses thereof in medicine | |
| US9447140B2 (en) | Cholest-4-en-3-one oxime derivatives, pharmaceutical compositions containing same, and preparation method | |
| US11352367B2 (en) | Indene derivatives useful in treating pain and inflammation | |
| JP2010517958A (ja) | PDE5インヒビターとして有用な6−ベンジル−2,3,4,7−テトラヒドロ−インドロ[2,3−c]キノリン化合物 | |
| US10105373B2 (en) | Fused triterpene compounds and uses thereof | |
| CN116354935A (zh) | 一种p38 MAPK/MK2通路调节剂及其组合物、制备方法和用途 | |
| CN116444492A (zh) | 一种p38 MAPK/MK2通路调节剂及其组合物、制备方法和用途 | |
| US20260137676A1 (en) | Piperazine substituted phenol derivative and use thereof | |
| EP3413892B1 (en) | Tetrahydroisoquinoline derivatives | |
| US8530504B2 (en) | Pyrazolothiazole compound | |
| US20240336562A1 (en) | Compound serving as nlrp3 inhibitor | |
| US12274694B2 (en) | Dizocilpine derivatives as peripheral NMDA receptor antagonists | |
| AU2021321705A1 (en) | Novel cycloalkenone compound or salt thereof | |
| CN112243437A (zh) | 含丙烯酰基的核转运调节剂及其用途 | |
| EP2546255A1 (en) | Benzazepine compound | |
| US11420962B2 (en) | Indene derivatives useful in treating pain and inflammation | |
| WO2025067414A1 (zh) | 吡唑羧酸衍生物及其在医药上的应用 | |
| CN121001992A (zh) | 咪唑基与二硝基苯基结合的衍生物及其用途 | |
| HK40087434A (zh) | 新型环烯酮化合物或其盐 | |
| HK40087434B (en) | Novel cycloalkenone compound or salt thereof | |
| US20240400562A1 (en) | Compounds and compositions for treating conditions associated with lpa receptor activity | |
| CN116209655A (zh) | 突变型idh1和idh2抑制剂及其应用 | |
| HK40077141A (en) | Tetrahydroisoquinoline derivative |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |